Clinical Trials Browser

Phase NA × NIH × oblimersen × Clear all

NCT00070343 2014-01-06

Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301

Phase NA Unknown

Melanoma